Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:09 AM
Ignite Modification Date:
2025-12-25 @ 3:09 AM
NCT ID:
NCT01874405
Eligibility Criteria:
Inclusion Criteria:
* Transfusion- dependent patients (\> 2 years);
* Ongoing deferasirox therapy during the study period;
* ≥ 2 Magnetic Resonance scans (one at baseline and at least one post baseline - as per clinical need) during study period (this criteria is not mandatory for patients undergoing only the endocrine subanalysis and participating only to the cardiac analysis);
* Available medical history including relevant clinical and laboratory data (e.g serum ferritin, liver function tests, renal function tests, endocrine parameters ) at baseline before starting deferasirox treatment
Exclusion Criteria:
* Non transfusion- dependent patients;
* Other chelation therapy than deferasirox;
* Absence of complete medical history as above specified
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Study:
NCT01874405
Study Brief:
Protocol Section:
NCT01874405